Clinical Evaluation of Low Contrast Visual Performance and Low Light Phenomena in Patients With Various Intraocular Lens Implants

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age22+
SponsorDr. Daniel H. Chang, MD

About this trial

The goal of this clinical investigation is to evaluate visual acuity and contrast sensitivity in low lighting conditions using several different testing devices, and measure nighttime side effects of intraocular lens (IOL) implants after cataract surgery.

Researchers will compare the results for three different types of IOLs to see how each lens contributes to overall visual function, patient experience and satisfaction.

Participants will:

* Complete two different questionnaires about their current vision * Undergo visual testing using several different devices

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Minimum 22 years of age

Bilateral pseudophakia, at least 3 months postoperative from IOL implantation, with one of the study IOL models in at least one eye.

Availability, willingness, and sufficient cognitive awareness to comply with examination procedures

Signed informed consent and HIPAA authorization or equivalent documentation necessary to comply with applicable privacy laws pertaining to medical treatment in the governing countries

Disqualifiers

Any clinically significant pupil abnormalities (non-reactive, fixed pupils, or abnormally shaped pupils.

Inability to focus or fixate for prolonged periods of time (e.g., due to strabismus, nystagmus, etc.)

Uncorrected distance visual acuity worse than 20/25 in either eye

Prior corneal refractive surgery (LASIK, LASEK, RK, PRK, etc.) or intraocular surgery. Note: Prophylactic peripheral iridotomies and peripheral laser retinal repairs that, in the opinion of the investigator will not confound study outcomes are acceptable.

Trial population

Bilateral pseudophakia, at least 3 months postoperative from IOL implantation with one of the study IOL models.

Trial design

Design model

Case-only

Time perspective

Prospective

Treatments tested in this trial

  • None-placebo

    Other intervention

    No interventions, only post-market, post-implantation observation.

Treatment groups

120 Participants
are divided into 3 treatment groups
Group A: Tecnis Monofocals1 intervention
Group B: Tecnis Symfony Optiblue1 intervention
Group C: Tecnis Odyssey1 intervention

Trial outcomes

Primary outcomes

1

Low (50%) contrast defocus curve

Measured low (50%) contrast defocus curve compared between all three groups

Time frame
Day 1
2

Halometry assessment of photic phenomena

Halometry assessment of halos and starbursts utilizing a cool white light with varying intensities. Comparing the measured size of the ring (deg) of each condition between all three groups.

Time frame
Day 1
3

PRVSQv2 questionnaire results

PRVSQv2 questionnaire results compared between all three groups: Frequency and bother/severity of symptoms (scale 1 to 5, with 5 most bothersome)

Time frame
Day 1

Secondary outcomes

1

Best corrected distance visual acuity (BCDVA)

Best corrected distance visual acuity (BCDVA) compared between all three groups

Time frame
Day 1
2

Low contrast (50%) BCDVA

Low contrast (50%) BCDVA compared between all three groups

Time frame
Day 1
3

Contrast Sensitivity

Contrast sensitivity compared between all three groups

Time frame
Day 1
4

High Contrast Defocus Curve

High Contrast Defocus Curve compared between all three groups

Time frame
Day 1

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Dr. Daniel H. Chang, MD

Lead sponsor

Empire Eye and Laser Center

Sponsor institution

Johnson & Johnson Surgical Vision, Inc.

Collaborator